Body Composition at Diagnosis and Early Response in Pediatric Hodgkin Lymphoma
- PMID: 39817816
- PMCID: PMC11968239
- DOI: 10.1158/1055-9965.EPI-24-1231
Body Composition at Diagnosis and Early Response in Pediatric Hodgkin Lymphoma
Abstract
Background: The association between skeletal, muscle, and adipose tissue (body composition) and early response using PET in pediatric Hodgkin lymphoma remains unstudied.
Methods: Patients enrolled on Children's Oncology Group studies AHOD0031 (intermediate-risk Hodgkin lymphoma) and AHOD0831 (high-risk Hodgkin lymphoma) with digital abdominal CT scans at diagnosis and PET scans after 2 cycles (PET2) were included. Two consecutive slices at the third lumbar vertebra were identified, and skeletal muscle index (SMI; in cm2/m2) and total adipose tissue index (TATI; in cm2/m2) were calculated using sliceOmatic and height at diagnosis. SMI and TATI were divided into quintiles [Q1 (lowest) to Q5 (highest)]. Body mass index (BMI) was calculated using height and weight at diagnosis. The association between baseline body composition (SMI, TATI, and BMI) and positive PET2 was examined using logistic regression, adjusting for age at diagnosis, sex, race/ethnicity, stage, histology, bulk disease, and "B" symptoms.
Results: Among 1,033 included patients, PET2 was positive in 314 (30.4%) patients. SMI was not associated with positive PET2. Extremes of TATI were associated with positive PET2, when compared with the middle TATI quintile [reference: Q3; ORQ1 = 1.63; 95% confidence interval (CI) = 1.03-2.60; P = 0.04; ORQ2 = 1.82; 95% CI = 1.17-2.82; P = 0.008; ORQ5 = 1.94; 95% CI = 1.23-3.05; P = 0.005]. The association between BMI in obesity range and positive PET2 trended toward significance (OR = 1.42; 95% CI = 0.98-2.04; P = 0.06; ref = normal weight).
Conclusions: Extremes of adipose tissue at diagnosis influence early response among pediatric Hodgkin lymphoma.
Impact: Validation of results from this study could inform studies investigating body composition-based chemotherapy dosing.
©2025 American Association for Cancer Research.
Conflict of interest statement
Similar articles
-
Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Using a Longitudinally Aware Segmentation Network.Radiol Artif Intell. 2025 May;7(3):e240229. doi: 10.1148/ryai.240229. Radiol Artif Intell. 2025. PMID: 39969278
-
Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High-Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331.Pediatr Blood Cancer. 2025 Sep;72(9):e31856. doi: 10.1002/pbc.31856. Epub 2025 Jun 14. Pediatr Blood Cancer. 2025. PMID: 40515508 Clinical Trial.
-
Body composition changes in pediatric patients with lymphoma after chemotherapy: a retrospective study.Eur J Pediatr. 2025 Feb 6;184(2):180. doi: 10.1007/s00431-025-06011-0. Eur J Pediatr. 2025. PMID: 39912930
-
Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphoma.Cochrane Database Syst Rev. 2015 Jan 9;1(1):CD010533. doi: 10.1002/14651858.CD010533.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2025 Mar 26;3:CD010533. doi: 10.1002/14651858.CD010533.pub3. PMID: 25572491 Free PMC article. Updated.
-
Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2. Cochrane Database Syst Rev. 2017. PMID: 28901021 Free PMC article.
References
-
- Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33(5):997–1006. - PubMed
-
- Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31(12):1539–47. - PubMed
-
- Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–35. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical